Tag: Cisplatin
-
Nation & World
Insight on triple-negative breast cancer
Scientists from Harvard-affiliated Brigham and Women’s Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive “triple-negative” breast cancers and certain ovarian cancers are likely to respond to platinum-based chemotherapies.
-
Nation & World
Improving a cancer drug
Researchers, led by Harvard Medical School Assistant Professor Shiladitya Sengupta, have devised a way to improve a low-cost, effective cancer drug, cisplatin, whose use has been limited by its toxicity.